Sequential Grafting of Fresh and Cryopreserved Fat After Mechanical Processing is a Safe and Effective Facial Rejuvenation Strategy

Quan, Yuping; Wang, Jing; Lu, Feng; Yuan, Yi; Cai, Junrong

doi:10.1007/s00266-022-02865-z

Cited by 7 publications

(4 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, it remains unclear whether the cryopreservation of BAOs may be associated with lower viability and metabolic activity. Freezing and thawing, the use of cryoprotective agents, and alterations to gene expression may all cause damage (Quan et al, 2022). Therefore, further research is needed to optimize cryopreservation protocols to ensure the viability and metabolic activity of these organoids.…”

Section: Discussionmentioning

confidence: 99%

Transplantation of beige adipose organoids fabricated using adipose acellular matrix hydrogel improves metabolic dysfunction in high‐fat diet‐induced obesity and type 2 diabetes mice

Quan,

Li,

Cai

et al. 2024

Journal Cellular Physiology

Self Cite

View full text Add to dashboard Cite

Transplantation of brown adipose tissue (BAT) is a promising approach for treating obesity and metabolic disorders. However, obtaining sufficient amounts of functional BAT or brown adipocytes for transplantation remains a major challenge. In this study, we developed a hydrogel that combining adipose acellular matrix (AAM) and GelMA and HAMA that can be adjusted for stiffness by modulating the duration of light‐crosslinking. We used human white adipose tissue‐derived microvascular fragments to create beige adipose organoids (BAO) that were encapsulated in either a soft or stiff AAM hydrogel. We found that BAOs cultivated in AAM hydrogels with high stiffness demonstrated increased metabolic activity and upregulation of thermogenesis‐related genes. When transplanted into obese and type 2 diabetes mice, the HFD + BAO group showed sustained improvements in metabolic rate, resulting in significant weight loss and decreased blood glucose levels. Furthermore, the mice showed a marked reduction in nonalcoholic liver steatosis, indicating improved liver function. In contrast, transplantation of 2D‐cultured beige adipocytes failed to produce these beneficial effects. Our findings demonstrate the feasibility of fabricating beige adipose organoids in vitro and administering them by injection, which may represent a promising therapeutic approach for obesity and diabetes.

show abstract

Section: Discussionmentioning

confidence: 99%

Transplantation of beige adipose organoids fabricated using adipose acellular matrix hydrogel improves metabolic dysfunction in high‐fat diet‐induced obesity and type 2 diabetes mice

Quan,

Li,

Cai

et al. 2024

Journal Cellular Physiology

Self Cite

View full text Add to dashboard Cite

show abstract

“…The need for a secondary filling is usually assessed 3 months after the first procedure for indication. The clinical experience of a surgeon and patient‐based requests are both the parameters for indication of a second procedure 23 . We believe that in the premise of improved proficiency, the outcomes are worth the cost of the moderately increased procedure complexity.…”

Section: Discussionmentioning

confidence: 99%

“…The need for a secondary filling is usually assessed 3 months after the first procedure for indication. The clinical experience of a surgeon and patient-based requests are both the parameters for indication of a second procedure 23. We believe that in the premise of improved proficiency, the outcomes are worth the cost of the moderately increased procedure complexity.Current studies of fat grafting have advanced our understanding of the dynamic progression of grafted fat tissue, postoperative clinical progress, clinical indications, and predictors of outcomes.…”

mentioning

confidence: 99%

Pyramidal multiple‐theory (multi‐type, multi‐method and multi‐layer) for facial fat grafting

Shi

Qian

et al. 2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background Age‐related changes to the face pertinent anatomy and important aspects of autologous fat grafting have been widely applied in facial rejuvenation. Various types of autologous fat products (Macrofat, Microfat, SEFF, nanofat, and SVF‐gel) with different properties and applicabilities have been introduced and available for surgeons. Methods Key differences between common techniques for fat processing and infiltration. Develop a plan for patients based on site‐specific facial anatomical zones, we suggested a pyramidal multiple‐theory (multi‐type, multi‐method and multi‐layer) for facial fat grafting. Based on the complicated mechanism of the face decrepitude in different layers of facial soft tissue, autologous fat products with various particle sizes and components into different layers. Results Fifty‐eight patients underwent this facial fat grafting strategy from June 2020 to Jan 2022. All achieved cosmetic improvements, with higher patients' satisfaction, and minor complications. Our facial fat grafting strategy takes advantage of different fat products and is able to address the physiological tissue changes during aging, more properly and targetedly, than the traditional facial fat grafting. Conclusions Fat grafting to the face aids in volume restoration and rejuvenation, thereby addressing soft‐tissue atrophy associated with the aging face, acquired conditions, or congenital malformations. The technique described as “lipo‐tumescence” has been successfully used in the breast and other regions of the body that have radiation damage and is discussed in this article specifically for the face and neck.

show abstract

“…Our previous study showed that cryopreserved stromal vascular fraction gel (SVF gel), an adipose-derived product that concentrates stromal vascular fraction cells, maintained tissue integrity and cell viability and was associated with a better long-term retention rate than that of cryopreserved fat . Clinical application of cryopreserved SVF gel for aesthetic is associated with safe and effective outcomes . However, whether it could exert a positive association with improving skin sclerosis remains unclear.…”

Section: Introductionmentioning

confidence: 99%

Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea

Liu,

Wang,

Zhang

et al. 2024

JAMA Dermatol

Self Cite

View full text Add to dashboard Cite

ImportanceMorphea is a rare disease of unknown etiology without satisfactory treatment for skin sclerosis and soft tissue atrophy.ObjectiveTo provide clinical, histologic, and transcriptome evidence of the antisclerotic and regenerative effects of sequential fat grafting with fresh fat and cryopreserved stromal vascular fraction gel (SVF gel) for morphea.Design, Setting, and ParticipantsThis single-center, nonrandomized controlled trial was conducted between January 2022 and March 2023 in the Department of Plastic and Reconstructive Surgery of Nanfang Hospital, Southern Medical University and included adult participants with early-onset or late-onset morphea who presented with varying degrees of skin sclerosis and soft tissue defect.InterventionsGroup 1 received sequential grafting of fresh fat and cryopreserved SVF gel (at 1 and 2 months postoperation). Group 2 received single autologous fat grafting. All patients were included in a 12-month follow-up.Main Outcome and MeasuresThe primary outcome included changes in the modified Localized Scleroderma Skin Severity Index (mLoSSI) and Localized Scleroderma Skin Damage Index (LoSDI) scores as evaluated by 2 independent blinded dermatologists. The histologic and transcriptome changes of morphea skin lesions were also evaluated.ResultsOf 44 patients (median [IQR] age, 26 [23-33] years; 36 women [81.8%]) enrolled, 24 (54.5%) were assigned to group 1 and 20 (45.5%) to group 2. No serious adverse events were noted. The mean (SD) mLoSSI scores at 12 months showed a 1.6 (1.50) decrease in group 1 and 0.9 (1.46) in group 2 (P = .13), whereas the mean (SD) LoSDI scores at 12 months showed a 4.3 (1.34) decrease in group 1 and 2.1 (1.07) in group 2 (P &lt; .001), indicating that group 1 had more significant improvement in morphea skin damage but not disease activity compared with group 2. Histologic analysis showed improved skin regeneration and reduced skin sclerosis in group 1, whereas skin biopsy specimens of group 2 patients did not show significant change. Transcriptome analysis of skin biopsy specimens from group 1 patients suggested that tumor necrosis factor α signaling via NFκB might contribute to the immunosuppressive and antifibrotic effect of sequential fat grafting. A total of 15 hub genes were captured, among which many associated with morphea pathogenesis were downregulated and validated by immunohistochemistry, such as EDN1, PAI-1, and CTGF.Conclusions and RelevanceThe results of this nonrandomized trial suggest that sequential fat grafting with fresh fat and cryopreserved SVF gel was safe and its therapeutic effect was superior to that of single autologous fat grafting with improved mLoSSI and LoSDI scores. Histological and transcriptomic changes further support the effectiveness after treatment.Trial RegistrationChinese Clinical Trial Registry identifier: ChiCTR2200058003

show abstract

Sequential Grafting of Fresh and Cryopreserved Fat After Mechanical Processing is a Safe and Effective Facial Rejuvenation Strategy

Cited by 7 publications

References 25 publications

Transplantation of beige adipose organoids fabricated using adipose acellular matrix hydrogel improves metabolic dysfunction in high‐fat diet‐induced obesity and type 2 diabetes mice

Transplantation of beige adipose organoids fabricated using adipose acellular matrix hydrogel improves metabolic dysfunction in high‐fat diet‐induced obesity and type 2 diabetes mice

Pyramidal multiple‐theory (multi‐type, multi‐method and multi‐layer) for facial fat grafting

Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea

Contact Info

Product

Resources

About